Investor Presentaiton slide image

Investor Presentaiton

31st January 2024 Our US strategy of selective play pays Revenue (INR Cr.) 17% CAGR 696 637 828 54 ANDA approvals (includes 2 tentative) 44 Products on shelf 516 FY20 FY21 FY22 FY23 4 Launched during 9M FY 2024 (1 more in Q4 FY 2024) 22 Pending approvals 6 ANDA filed in 9M FY 2024, target 6~8 this year 19 ajanta
View entire presentation